David Emerson Jorden - Net Worth and Insider Trading
David Emerson Jorden Net Worth
The estimated net worth of David Emerson Jorden is at least $3 Million dollars as of 2024-12-28. David Emerson Jorden is the CEO/CFO of Nuo Therapeutics Inc and owns about 1,975,358 shares of Nuo Therapeutics Inc (AURX) stock worth over $3 Million. David Emerson Jorden is also the Acting CFO, 10% Owner of PLx Pharma Winddown Corp and owns about 151,913 shares of PLx Pharma Winddown Corp (PLXPQ) stock worth over $30. Details can be seen in David Emerson Jorden's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Emerson Jorden has not made any transactions after 2022-11-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Emerson Jorden
David Emerson Jorden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Emerson Jorden owns 5 companies in total, including Nuo Therapeutics Inc (AURX) , PLx Pharma Winddown Corp (PLXPQ) , and Acer Therapeutics Inc (ACER) among others .
Click here to see the complete history of David Emerson Jorden’s form 4 insider trades.
Insider Ownership Summary of David Emerson Jorden
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AURX | Nuo Therapeutics Inc | 2022-11-09 | director & CEO & CFO |
| PLXPQ | PLx Pharma Winddown Corp | 2017-06-14 | Acting Chief Financial Officer |
| ACER | Acer Therapeutics Inc | 2010-06-09 | director |
 | | 2011-03-09 | director & 10 percent owner |
| | 2011-03-09 | director & 10 percent owner |
David Emerson Jorden Latest Holdings Summary
David Emerson Jorden currently owns a total of 2 stocks. Among these stocks, David Emerson Jorden owns 1,975,358 shares of Nuo Therapeutics Inc (AURX) as of November 9, 2022, with a value of $3 Million and a weighting of 100%. David Emerson Jorden also owns 151,913 shares of PLx Pharma Winddown Corp (PLXPQ) as of June 14, 2017, with a value of $30 and a weighting of 0%.
Latest Holdings of David Emerson Jorden
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AURX | Nuo Therapeutics Inc | 2022-11-09 | 1,975,358 | 1.53 | 3,027,236 |
| PLXPQ | PLx Pharma Winddown Corp | 2017-06-14 | 151,913 | 0.00 | 30 |
Holding Weightings of David Emerson Jorden
David Emerson Jorden Form 4 Trading Tracker
According to the SEC Form 4 filings, David Emerson Jorden has made a total of 1 transactions in Nuo Therapeutics Inc (AURX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nuo Therapeutics Inc is the sale of 162,500 shares on November 9, 2022, which brought David Emerson Jorden around $243,750.
According to the SEC Form 4 filings, David Emerson Jorden has made a total of 0 transactions in PLx Pharma Winddown Corp (PLXPQ) over the past 5 years. The most-recent trade in PLx Pharma Winddown Corp is the acquisition of 32,727 shares on June 14, 2017, which cost David Emerson Jorden around $225,162.
Insider Trading History of David Emerson Jorden
- 1
David Emerson Jorden Trading Performance
GuruFocus tracks the stock performance after each of David Emerson Jorden's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Emerson Jorden is -6.67%. GuruFocus also compares David Emerson Jorden's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Emerson Jorden within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Emerson Jorden's insider trading performs compared to the benchmark.
Performance of David Emerson Jorden
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.67 | | | | | |
| Relative Return to S&P 500(%) | -7.55 | | | | | |
David Emerson Jorden Ownership Network
David Emerson Jorden Owned Company Details
What does Nuo Therapeutics Inc do?
Who are the key executives at Nuo Therapeutics Inc?
David Emerson Jorden is the director & CEO & CFO of Nuo Therapeutics Inc. Other key executives at Nuo Therapeutics Inc include 10 percent owner Charles E Sheedy , CSO Peter Clausen , and 10 percent owner Boyalife Investment Fund I, Inc. .
Nuo Therapeutics Inc (AURX) Insider Trades Summary
Over the past 18 months, David Emerson Jorden made no insider transaction in Nuo Therapeutics Inc (AURX). Other recent insider transactions involving Nuo Therapeutics Inc (AURX) include a net purchase of 437,500 shares made by Charles E Sheedy ,
In summary, during the past 3 months, insiders sold 0 shares of Nuo Therapeutics Inc (AURX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nuo Therapeutics Inc (AURX) were sold and 437,500 shares were bought by its insiders, resulting in a net purchase of 437,500 shares.
Nuo Therapeutics Inc (AURX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nuo Therapeutics Inc Insider Transactions
David Emerson Jorden Mailing Address
Above is the net worth, insider trading, and ownership report for David Emerson Jorden. You might contact David Emerson Jorden via mailing address: 2635 Technology Forest Blvd., The Woodlands Tx 77381.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
